262 related articles for article (PubMed ID: 28669130)
21. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of Basiliximab and Alemtuzumab induction therapies in blood type A2-to-B kidney transplantation: Impact on kidney function and de novo donor-specific HLA antibodies.
Hanouneh T; Attieh RM; Craver E; Jebrini A; Elrefaei M; Jarmi T
Transpl Immunol; 2023 Dec; 81():101958. PubMed ID: 37949378
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of induction therapy with alemtuzumab in kidney transplantation: a meta-analysis.
Shou ZF; Zhou Q; Cai JR; Cheng J; He Q; Wu JY; Chen JH
Chin Med J (Engl); 2009 Jul; 122(14):1692-8. PubMed ID: 19719973
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection.
van der Zwan M; Clahsen-Van Groningen MC; van den Hoogen MWF; Kho MML; Roodnat JI; Mauff KAL; Roelen DL; van Agteren M; Baan CC; Hesselink DA
Front Immunol; 2020; 11():1332. PubMed ID: 32719676
[TBL] [Abstract][Full Text] [Related]
25. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
Pascual J; Pirsch JD; Odorico JS; Torrealba JR; Djamali A; Becker YT; Voss B; Leverson GE; Knechtle SJ; Sollinger HW; Samaniego-Picota MD
Transplantation; 2009 Jan; 87(1):125-32. PubMed ID: 19136902
[TBL] [Abstract][Full Text] [Related]
26. Primary pediatric live-donor-kidney transplant-recipients' outcomes by immunosuppression induction received in the United States.
Riad S; Jackson S; Chinnakotla S; Verghese P
Pediatr Transplant; 2021 Aug; 25(5):e13925. PubMed ID: 33333629
[TBL] [Abstract][Full Text] [Related]
27. In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.
Todeschini M; Cortinovis M; Perico N; Poli F; Innocente A; Cavinato RA; Gotti E; Ruggenenti P; Gaspari F; Noris M; Remuzzi G; Casiraghi F
J Immunol; 2013 Sep; 191(5):2818-28. PubMed ID: 23913968
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience.
Yakubu I; Ravichandran B; Sparkes T; Barth RN; Haririan A; Masters B
J Pharm Pract; 2021 Apr; 34(2):199-206. PubMed ID: 31315501
[TBL] [Abstract][Full Text] [Related]
29. Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction.
Weissenbacher A; Hautz T; Kimelman M; Oberhuber R; Ulmer H; Bösmüller C; Maglione M; Schneeberger S
J Immunol Res; 2015; 2015():985460. PubMed ID: 26171403
[TBL] [Abstract][Full Text] [Related]
30. Basiliximab: a review of its use as induction therapy in renal transplantation.
Chapman TM; Keating GM
Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up.
Ciancio G; Burke GW; Gaynor JJ; Roth D; Kupin W; Rosen A; Cordovilla T; Tueros L; Herrada E; Miller J
Clin Transplant; 2008; 22(2):200-10. PubMed ID: 18339140
[TBL] [Abstract][Full Text] [Related]
32. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
Cai J; Terasaki PI
Transplantation; 2010 Dec; 90(12):1511-5. PubMed ID: 21057388
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Induction Therapy in Kidney Transplantation: A Network Meta-Analysis.
Hwang SD; Lee JH; Lee SW; Park KM; Kim JK; Kim MJ; Song JH
Transplant Proc; 2018 May; 50(4):987-992. PubMed ID: 29731098
[TBL] [Abstract][Full Text] [Related]
34. Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
Lentine KL; Schnitzler MA; Xiao H; Brennan DC
Trials; 2015 Aug; 16():365. PubMed ID: 26285695
[TBL] [Abstract][Full Text] [Related]
35. Alemtuzumab induction in renal transplantation.
Hanaway MJ; Woodle ES; Mulgaonkar S; Peddi VR; Kaufman DB; First MR; Croy R; Holman J;
N Engl J Med; 2011 May; 364(20):1909-19. PubMed ID: 21591943
[TBL] [Abstract][Full Text] [Related]
36. Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantation.
Zwart TC; Bezstarosti S; Achini FR; Reinders MEJ; Schilham MW; Heidt S; Guchelaar HJ; de Fijter JW; Moes DJAR
Br J Clin Pharmacol; 2023 Apr; 89(4):1471-1485. PubMed ID: 36408784
[TBL] [Abstract][Full Text] [Related]
37. Low Immunologic Risk Living Related Renal Transplant Using Very Low-Dose Antithymocyte Globulin as Induction Therapy: A Single Tertiary Hospital Experience.
Jalalonmuhali M; Ng KP; Ong CS; Lee YW; Wan Md Adnan WAH; Lim SK
Transplant Proc; 2020; 52(6):1709-1714. PubMed ID: 32448669
[TBL] [Abstract][Full Text] [Related]
38. Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience.
Huang HF; Zhou JY; Xie WQ; Wu JY; Deng H; Chen JH
Int Urol Nephrol; 2016 Aug; 48(8):1363-1370. PubMed ID: 27170340
[TBL] [Abstract][Full Text] [Related]
39. Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients.
Cahoon WD; Ensor CR; Shullo MA
Prog Transplant; 2012 Dec; 22(4):344-9; quiz 350. PubMed ID: 23187050
[TBL] [Abstract][Full Text] [Related]
40. A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation.
Magliocca JF; Odorico JS; Pirsch JD; Becker YT; Knechtle SJ; Leverson GE; Sollinger HW
Am J Transplant; 2008 Aug; 8(8):1702-10. PubMed ID: 18694474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
